Clinical and molecular associations with outcomes at two years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK)
Journal article
Garriga C. et al, (2021), Lancet rheumatology
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Journal article
Ewer KJ. et al, (2021), Nat med
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Journal article
Barrett JR. et al, (2021), Nat med
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Journal article
Barrett JR. et al, (2021), Nat med, 27, 279 - 288
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Journal article
Ewer KJ. et al, (2021), Nat med, 27, 270 - 278
Factors influencing the re-emergence of plague in Madagascar.
Journal article
Alderson J. et al, (2020), Emerg top life sci, 4, 411 - 421
Multisystem inflammatory syndrome in children: getting to the heart of the matter.
Journal article
Cavounidis A. et al, (2020), Nat rev immunol, 20
SARS-CoV-2: too infectious to handle?
Journal article
Coveney C. and Alderson J., (2020), Nat rev immunol, 20
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis.
Journal article
von Loga IS. et al, (2019), Ann rheum dis, 78, 672 - 675